ZNF503-AS2 is a promising therapeutic target and is...
Conclusions: ZNF503-AS2 might be a valuable biomarker for predicting the prognosis of glioma patients and a potential target for glioma therapy.Wu, YiboMu, GuangjingLi, FangSun, YanfeiLin, XiaoyingLiu, XuemengZhao, ZhiminHan, MingzhiWang, Donghai...